You are here: Industry Insights > Dexamethasone

News List

NICE recommends Kyprolis triple combination treatment for multiple myeloma pharmatimes
March 22, 2021
The National Institute for Health and Care Excellence (NICE) has recommended a triple combination therapy comprised of Amgen’s Kyprolis, lenalidomide and dexamethasone for the treatment of previously-treated multiple myeloma patients.
FDA Grants Accelerated Approval to Darzalex Faspro for Newly Diagnosed Light Chain Amyloidosis americanpharmaceuticalreview
January 27, 2021
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to daratumumab plus hyaluronidase (Darzalex Faspro, Janssen Biotech) in combination with bortezomib, cyclophosphamide and dexamethasone for newly diagnosed light chain (AL) ...
Antengene Announces Acceptance of IND Application in China for a Phase 3 Clinical Trial of ATG-010 (Selinexor) in Combination with Bortezomib and Dexamethasone (SVd) for the Treatment of rrMM prnasia
December 11, 2020
Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncology, announced that the National ...
Trial to compare dexamethasone and baricitinib in hospitalised COVID-19 patients europeanpharmaceuticalreview
November 27, 2020
The fourth iteration of the COVID-19 treatment trial will determine whether remdesivir plus baricitinib or dexamethasone, is more effective at promoting recovery from COVID-19.
NICE backs use of new treatment for multiple myeloma pharmatimes
November 27, 2020
Patients with a difficult to treat form of multiple myeloma will now gain access to a new treatment on the NHS in England and Wales, after cost regulators issued final guidance on the use of Sanofi's Sarclisa (isatuximab).
Study recommends steroid treatment should be given only to sickest COVID-19 patients expresspharma
November 16, 2020
While dexamethasone and other steroids are prescribed to treat cytokine storms, these drugs can backfire in patients whose immune response is already suppressed.
FDA Grants Priority Review of Melflufen for Triple-Class Refractory Multiple Myeloma americanpharmaceuticalreview
September 02, 2020
Oncopeptides has announced the US Food and Drug Administration (FDA) has granted priority review for Oncopeptides' New Drug Application seeking approval of melflufen (INN melphalan flufenamide), in combination with dexamethasone for ...
US expand use of Janssen's Darzalex pharmatimes
August 21, 2020
US regulators have approved Janssen's Darzalex (daratumumab) in combination with carfilzomib and dexamethasone (DKd) for the treatment of adults with relapsed/refractory multiple myeloma who have received one to three previous lines of therapy.
Dr Reddy’s Laboratories launches generic Ciprodex Otic Suspension, USP in US expresspharma
August 11, 2020
It is available as 7.5 mL fill in a 10 mL bottle.
Interleukin-6 inhibitors improve outcomes for COVID-19 patients in study europeanpharmaceuticalreview
August 06, 2020
Researchers have shown that symptoms in patients experiencing severe COVID-19 improved when given either sarilumab or tocilizumab, interleukin-6 inhibitors.

Previous page 1 2 3 4 Next page